Ocugen Inc
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
PGWFF PGG Wrightson Ltd
CRNX Crinetics Pharmaceuticals Inc
NDAQ Nasdaq Inc
PML PIMCO Municipal Income Fund II
BBLN Babylon Holdings Ltd
NEPT Neptune Wellness Solutions Inc
AEO American Eagle Outfitters Inc
BNS Bank of Nova Scotia
BAC Bank of America Corp
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine is developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a novel biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.

Closing Price
$6.03
Day's Change
0.06 (1.01%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.13
Day's Low
5.80
Volume
(Light)
Volume:
8,823,225

10-day average volume:
15,678,323
8,823,225
  • Prev Close
    5.97
  • Today's Open
    5.98
  • Day's Range
    5.80-6.13
  • Avg Vol (10-day)
    15.7M
  • Last (time)
    4:00p ET 12/08/21
  • Last (size)
    2.0K
  • 52-Wk Range
    0.285 - 18.77
    LowHigh
  • (12/10/20 - 02/08/21)
    2,015.79%
  • 250.6%
  • Market Cap
    1.2B
  • Shares Outstanding
    199.2M
  • -0.25
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 4.8
  • 27.00
  • (% of float 11/15/21)
    24.14

Latest News

December 08, 2021
5:14 pm ET
MarketWatch
December 06, 2021
5:13 pm ET
MarketWatch
December 03, 2021
5:14 pm ET
MarketWatch
December 02, 2021
5:13 pm ET
MarketWatch
December 01, 2021
5:13 pm ET
MarketWatch
November 30, 2021
5:13 pm ET
MarketWatch
November 29, 2021
5:13 pm ET
MarketWatch
November 26, 2021
7:01 am ET
Globe Newswire
November 24, 2021
5:13 pm ET
MarketWatch
November 23, 2021
5:13 pm ET
MarketWatch
November 22, 2021
5:13 pm ET
MarketWatch
November 19, 2021
5:13 pm ET
MarketWatch
November 18, 2021
5:13 pm ET
MarketWatch
4:03 pm ET
Globe Newswire
November 17, 2021
5:13 pm ET
MarketWatch
November 16, 2021
5:13 pm ET
MarketWatch
November 15, 2021
5:13 pm ET
MarketWatch
November 12, 2021
5:13 pm ET
MarketWatch
10:25 am ET
MarketWatch
November 11, 2021
5:13 pm ET
MarketWatch
November 10, 2021
5:13 pm ET
MarketWatch
November 09, 2021
5:13 pm ET
MarketWatch
10:41 am ET
PR Newswire
7:30 am ET
Globe Newswire
November 08, 2021
5:13 pm ET
MarketWatch
9:24 am ET
Globe Newswire
November 05, 2021
5:13 pm ET
MarketWatch
4:19 pm ET
PR Newswire
6:38 am ET
Globe Newswire
November 04, 2021
5:20 pm ET
MarketWatch
November 03, 2021
5:14 pm ET
MarketWatch
8:58 am ET
PR Newswire
November 02, 2021
6:17 pm ET
Globe Newswire
5:13 pm ET
MarketWatch
10:45 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.